Skip to results
1-16 of 16
Authors: Ryusuke Hatae
Sort by
Journal Article
Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model Open Access
Ryusuke Hatae and others
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf074, https://doi.org/10.1093/noajnl/vdaf074
Published: 12 April 2025
Journal Article
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma Open Access
Ryosuke Otsuji and others
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae069, https://doi.org/10.1093/noajnl/vdae069
Published: 08 May 2024
Journal Article
10098-MPC-10 HOW SHOULD WE RESPOND TO REPEATED WHO REVISIONS? IN-HOUSE MOLECULAR DIAGNOSIS SYSTEM BY ADVANCED MEDICAL SYSTEM Open Access
Nobuhiro Hata and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Pages v11–v12, https://doi.org/10.1093/noajnl/vdad141.045
Published: 10 December 2023
Journal Article
PATH-28. OUTCOME IMPACT OF THE CDKN2A/B HEMI-ZYGOUS DELETION IN IDH-MUTANT ASTROCYTOMA Free
Ryosuke Otsuji and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v173–v174, https://doi.org/10.1093/neuonc/noad179.0658
Published: 10 November 2023
Journal Article
EXTH-18. DEVELOPMENT OF A TRANSGENIC MOUSE MODEL ENABLING COMPARATIVE ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING IMMUNE CELL POPULATIONS FOR CANCER IMMUNOTHERAPY Free
Ryusuke Hatae and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v227, https://doi.org/10.1093/neuonc/noad179.0872
Published: 10 November 2023
Journal Article
IMMU-04. LOW-INTENSITY PULSED ULTRASOUND ENHANCES CAR T CELL THERAPY BY INDUCING TWO-WAY IMMUNE CELL TRAFFICKING – T CELL INTO TUMOR AND MYELOID CELL INTO PERIPHERY IN A SYNGENEIC MOUSE GLIOBLASTOMA MODEL Free
Akane Yamamichi and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v141–v142, https://doi.org/10.1093/neuonc/noad179.0536
Published: 10 November 2023
Journal Article
EXTH-06. PRE-INFUSION METABOLIC MODULATION OF CAR-T CELLS PROMOTES THE RESISTANCE TO THE SUPPRESSIVE EFFECTS OF HYPOXIA AND ENHANCES ANTI-TUMOR EFFECTS AGAINST INTRACEREBRAL GLIOMAS Free
Ryusuke Hatae and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii209–vii210, https://doi.org/10.1093/neuonc/noac209.805
Published: 14 November 2022
Journal Article
Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas Free
Hanae Takase and others
British Journal of Radiology, Volume 95, Issue 1133, 1 May 2022, 20210392, https://doi.org/10.1259/bjr.20210392
Published: 09 February 2022
Journal Article
Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice Free
Pavlina Chuntova and others
Neuro-Oncology, Volume 24, Issue 2, February 2022, Pages 259–272, https://doi.org/10.1093/neuonc/noab182
Published: 04 August 2021
Journal Article
HGG-24. HIGH-GRADE GLIOMA WITH A NOVEL FUSION GENE OF VCL-ALK Open Access
Shunsuke Yamamoto and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii348, https://doi.org/10.1093/neuonc/noaa222.309
Published: 04 December 2020
Journal Article
TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS Open Access
Yuhei Sangatsuda and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii468, https://doi.org/10.1093/neuonc/noaa222.836
Published: 04 December 2020
Journal Article
ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application Open Access
Yusuke Funakoshi and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Pages ii7–ii8, https://doi.org/10.1093/noajnl/vdaa143.032
Published: 28 November 2020
Journal Article
IM-03 CD206 expression in peripheral blood-derived induced-microglia-like cells as a surrogate biomarker for the specific immune microenvironment of glioma Open Access
Nobuhiro Hata and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii7, https://doi.org/10.1093/noajnl/vdaa143.031
Published: 28 November 2020
Journal Article
MPC-06 Cutting-edge of Cancer Genomic Medicine for brain tumors Open Access
Masahiro Mizoguchi and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii12, https://doi.org/10.1093/noajnl/vdaa143.051
Published: 28 November 2020
Journal Article
ACT-16 THE POTENTIAL OF HYPOFRACTIONATED RADIOTHERAPY AND BEVACIZUMAB FOR GLIOBLASTOMA TREATMENT Open Access
Nobuhiro Hata and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii15, https://doi.org/10.1093/noajnl/vdz039.065
Published: 16 December 2019
Journal Article
QUANTIFICATION OF PRONEURAL GENE-EXPRESSION SIGNATURE OF GLIOMAS AND GLIOBLASTOMA-DERIVED SPHERES
Get access
Koji Yoshimoto and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii51, https://doi.org/10.1093/neuonc/nou209.37
Published: 01 July 2014